About 1 result found for searched term "BBT-176" (0.121 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M40638 | BBT-176 | EGFR/HER2 |
| BBT-176 is a novel, EGFR tyrosine kinase inhibitor (TKI) targeting the C797S mutation for studies related to non-small cell lung cancer (NSCLC). | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
